Central efferent pathways for cold-defensive and febrile shivering

J Physiol. 2011 Jul 15;589(Pt 14):3641-58. doi: 10.1113/jphysiol.2011.210047. Epub 2011 May 24.

Abstract

Shivering is a remarkable somatomotor thermogenic response that is controlled by brain mechanisms. We recorded EMGs in anaesthetized rats to elucidate the central neural circuitry for shivering and identified several brain regions whose thermoregulatory neurons comprise the efferent pathway driving shivering responses to skin cooling and pyrogenic stimulation. We simultaneously monitored parameters from sympathetic effectors: brown adipose tissue (BAT) temperature for non-shivering thermogenesis and arterial pressure and heart rate for cardiovascular responses. Acute skin cooling consistently increased EMG, BAT temperature and heart rate and these responses were eliminated by inhibition of neurons in the median preoptic nucleus (MnPO) with nanoinjection of muscimol. Stimulation of the MnPO evoked shivering, BAT thermogenesis and tachycardia, which were all reversed by antagonizing GABA(A) receptors in the medial preoptic area (MPO). Inhibition of neurons in the dorsomedial hypothalamus (DMH) or rostral raphe pallidus nucleus (rRPa) with muscimol or activation of 5-HT1A receptors in the rRPa with 8-OH-DPAT eliminated the shivering, BAT thermogenic, tachycardic and pressor responses evoked by skin cooling or by nanoinjection of prostaglandin (PG) E2, a pyrogenic mediator, into the MPO. These data are summarized with a schematic model in which the shivering as well as the sympathetic responses for cold defence and fever are driven by descending excitatory signalling through the DMH and the rRPa, which is under a tonic inhibitory control from a local circuit in the preoptic area. These results provide the interesting notion that, under the demand for increasing levels of heat production, parallel central efferent pathways control the somatic and sympathetic motor systems to drive thermogenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Adipose Tissue, Brown / drug effects
  • Adipose Tissue, Brown / physiology
  • Animals
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Body Temperature Regulation / physiology*
  • Cold Temperature
  • Dinoprostone / pharmacology
  • Efferent Pathways / metabolism
  • Efferent Pathways / physiology*
  • Fever / metabolism
  • Fever / physiopathology*
  • GABA-A Receptor Antagonists / metabolism
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Male
  • Mediodorsal Thalamic Nucleus / drug effects
  • Mediodorsal Thalamic Nucleus / metabolism
  • Mediodorsal Thalamic Nucleus / physiology
  • Medulla Oblongata / drug effects
  • Medulla Oblongata / metabolism
  • Medulla Oblongata / physiology
  • Muscimol / pharmacology
  • N-Methylaspartate / pharmacology
  • Neural Pathways / drug effects
  • Neural Pathways / metabolism
  • Neural Pathways / physiology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / physiology
  • Preoptic Area / drug effects
  • Preoptic Area / metabolism*
  • Preoptic Area / physiology*
  • Raphe Nuclei / drug effects
  • Raphe Nuclei / metabolism
  • Raphe Nuclei / physiology
  • Rats
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1A / metabolism
  • Receptors, GABA-A / metabolism
  • Shivering / drug effects
  • Shivering / physiology*
  • Skin Temperature / physiology
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiology
  • Tachycardia / metabolism
  • Tachycardia / pathology
  • Thermogenesis / drug effects
  • Thermogenesis / physiology

Substances

  • GABA-A Receptor Antagonists
  • Receptors, GABA-A
  • Receptor, Serotonin, 5-HT1A
  • Muscimol
  • N-Methylaspartate
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • Dinoprostone